news

Tumours detected with sugar molecules

Scientists have synthesised a complex sugar structure that specifically binds to the tumour protein Galectin-1…

Tumours

Scientists have synthesised a complex sugar structure that specifically binds to the tumour protein Galectin-1, which could help to recognise tumours at an early stage and to combat them in a targeted manner.

“Among other things, it is known that galectin-1 hides the tumour cells from the immune system,” explains Professor Jürgen Seibel of the Institute of Organic Chemistry at the University of Würzburg. Recent studies have shown that when Galectin-1 is blocked, the immune system can recognise the tumour and attack it with T cells.

Galectin-1 has become a major focus of research for Prof Seibel and his research team, they are now interested in a very specific section of protein, the so-called carbohydrate recognition domain. The researchers are currently working on a rapid test for the detection of galectin-1. It is designed to enable early detection of tumours such as neuroblastoma.

“We have provided the sugar molecule with a docking site, for example, to connect it with a fluorescent dye or an active substance,” said Prof Seibel. In addition, the scientists have described the binding of their molecule to galectin-1 with high-resolution X-ray structure analyses.

“Our findings can serve the development of high-affinity ligands of the protein Galectin-1 and thus also new drugs,” said Dr Clemens Grimm

 

Reserve your FREE place

 


Are you advancing promising antibody leads, only to encounter issues with stability, PK or manufacturability later in development?

30 July 2025 | 10:00 AM BST | FREE Webinar

Join us for an expert-led webinar exploring how early-stage developability assessment can help reduce downstream risk and improve candidate selection.

What You’ll Learn:

  • How to identify key developability risks early including aggregation, PK, and manufacturability
  • How to implement high-throughput in vitro assays requiring <1 mg of antibody per test
  • How to combine in silico modeling with wet-lab analytics to guide early optimisation

Don’t miss your chance to learn from Dr Lei Guo.

Register Now – It’s Free!

 

For the future, Prof Seibel’s team would like to expand the sugar molecules into a kind of shuttle system that allows pharmaceutical agents to be transported directly to the tumours. The study has been published in ChemBioChem.

Leave a Reply

Your email address will not be published. Required fields are marked *